Stockscreener 앱 받기
9.765
2.25%
-0.225
Celcuity Inc 주식(CELC)의 최신 뉴스
Is Celcuity (NASDAQ:CELC) Using Debt Sensibly? - simplywall.st
Celcuity Inc. (NASDAQ:CELC) Stock Holdings Lifted by Vanguard Group Inc. - Defense World
Where are the Opportunities in (CELC) - news.stocktradersdaily.com
Celcuity Inc. (NASDAQ:CELC) Shares Purchased by Wellington Management Group LLP - Defense World
Corebridge Financial Inc. Has $213,000 Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
Needham & Company LLC Reiterates “Buy” Rating for Celcuity (NASDAQ:CELC) - Defense World
Celcuity at Needham Conference: New Frontiers in Cancer Treatment By Investing.com - Investing.com Canada
Celcuity at Stifel Forum: Insights on Cancer Drug Trials By Investing.com - Investing.com Canada
Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Celcuity projects $2B revenue potential for gedatolisib in second-line breast cancer market - MSN
What is HC Wainwright’s Forecast for Celcuity Q1 Earnings? - The AM Reporter
Celcuity Stock Hits 52-Week Low at $8.46 Amid Market Challenges - Investing.com Australia
Celcuity Stock Hits 52-Week Low at $8.46 Amid Market Challenges By Investing.com - Investing.com South Africa
Research Analysts Offer Predictions for Celcuity Q1 Earnings - Defense World
Celcuity Announces Closing of Common Stock Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares of Common Stock - ACCESS Newswire
Celcuity (NASDAQ:CELC) Receives Buy Rating from Needham & Company LLC - Defense World
Celcuity (NASDAQ:CELC) Given Buy Rating at HC Wainwright - Defense World
Brokerages Set Celcuity Inc. (NASDAQ:CELC) PT at $30.17 - Defense World
Celcuity Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update - ACCESS Newswire
Celcuity Stock (CELC) Dips Despite Promising Cancer Treatment in Pipeline - The Globe and Mail
Celcuity Inc. Earnings Call Highlights Progress and Challenges - TipRanks
Stifel maintains Celcuity stock Buy rating, $42 target By Investing.com - Investing.com Canada
Celcuity Inc (NASDAQ:CELC) Misses Earning Expectations - FXDailyReport.Com
Stifel maintains Celcuity stock Buy rating, $42 target - Investing.com
Celcuity Inc. (NASDAQ:CELC) Q4 2024 Earnings Call Transcript - Insider Monkey
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences - GlobeNewswire
Celcuity Inc. Reports 2024 Financial Results and Clinical Updates - TipRanks
Earnings call transcript: Celcuity Q4 2024 reveals wider losses By Investing.com - Investing.com Canada
Celcuity Inc. SEC 10-K Report - TradingView
Celcuity Inc reports results for the quarter ended December 31Earnings Summary - TradingView
CELCUITY Earnings Results: $CELC Reports Quarterly Earnings - Nasdaq
Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - The Manila Times
Earnings Scheduled For March 31, 2025 - Benzinga
(CELC) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Has $3.11 Million Stock Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
Bank of New York Mellon Corp Buys 10,828 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2024 Financial Results and Webcast/Conference Call - GlobeNewswire
Celcuity (CELC) Projected to Post Quarterly Earnings on Wednesday - Defense World
Celcuity at Leerink Global Healthcare Conference: Promising Cancer Drug Insights By Investing.com - Investing.com South Africa
Celcuity at Leerink Global Healthcare Conference: Promising Cancer Drug Insights - Investing.com Canada
BlackRock, Inc. Expands Holdings with Celcuity Inc. Acquisition - GuruFocus
Rhumbline Advisers Boosts Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
(CELC) Technical Data - Stock Traders Daily
Brokerages Set Celcuity Inc. (NASDAQ:CELC) Target Price at $30.17 - Defense World
Celcuity, Inc. to Host Earnings Call - ACCESS Newswire
New York State Common Retirement Fund Purchases 3,682 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025 - The Malaysian Reserve
(CELC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Celcuity stock touches 52-week low at $10.35 amid market challenges - Investing.com India
Celcuity stock touches 52-week low at $10.35 amid market challenges By Investing.com - Investing.com South Africa
Celcuity to Participate at Upcoming Cowen and Leerink Investor Conferences - The Manila Times
0.36%
0.47%
자본화:
|
볼륨(24시간):